High levels of osteopontin (OPN) mRNA and proteins were reported in atherosclerotic plaques. 1, 2 Recently, we reported plasma OPN levels to be high in patients with coronary artery disease (CAD) and to correlate with the severity of CAD. 3 However, no association between plasma OPN levels and restenosis after percutaneous coronary intervention (PCI) has yet been demonstrated.
arterial injury in animal models. 1 We generated OPN-overexpressing transgenic mice and demonstrated markedly increased neointimal formation after arterial injury. 5 Liaw et al 6 showed anti-osteopontin antibody treatment to reduce neointimal formation after injury in rat arteries. In humans, high levels of OPN mRNA and proteins were reported in atherectomy specimens from restenotic lesions. 7 Panda et al 2 showed plasma OPN levels in 13 patients undergoing coronary atherectomy to be elevated after atherectomy, and they remained high for at least 4 weeks. We showed plasma OPN levels to be higher in patients with than without restenosis and to be an independent factor for restenosis. OPN may play a role in the development of restenosis associated with neointimal proliferation.
Diabetes is a well-known clinical predictor of restenosis. In our study, diabetes was also a factor for restenosis. High glucose increases OPN mRNA in smooth muscle cells. 8 Increased OPN expression was shown in diabetic arteries. 9 Diabetes may thus facilitate restenosis via increased OPN production. However, OPN levels were a factor for restenosis independent of diabetes. Diabetes and increased OPN production may synergistically facilitate restenosis.
Our study was preliminary, because we did not measure OPN levels before PCI. Further study in a prospective manner is needed to elucidate the predictive value of plasma OPN levels before PCI for the development of restenosis. Moreover, we could not determine the main source of plasma OPN, because we did not measure OPN levels in coronary sinus.
Plasma OPN levels. Hypertension was defined as blood pressure Ն140/90 mm Hg or on drugs. Hyperlipidemia was defined as total cholesterol level Ͼ240 mg/dl or on drugs. Diabetes was defined as fasting glucose level Ն126 mg/dl or on hypoglycemic drugs or insulin.
ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blockers; hsCRP, high-sensitivity C-reactive protein.
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